Literature DB >> 9767736

Hormonal therapy of breast cancer.

G Y Locker1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9767736     DOI： 10.1016/s0305-7372(98)90051-2

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  8 in total

1.  Tumour markers in malignancies. Two isoforms of oestrogen receptor are now known to exist.

Authors:  C Palmieri; S Fishpool; R C Coombes
Journal:  BMJ       Date:  2000-08-05

Review 2.  Targeted functional imaging in breast cancer.

Authors:  Rakesh Kumar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-03       Impact factor: 9.236

3.  Over-expressed estrogen receptor-alpha up-regulates hTNF-alpha gene expression and down-regulates beta-catenin signaling activity to induce the apoptosis and inhibit proliferation of LoVo colon cancer cells.

Authors:  Hsi-Hsien Hsu; Sue-Fei Cheng; Li-Mien Chen; Jer-Yu Liu; Chun-Hsien Chu; Yi-Jiun Weng; Zih-Ying Li; Chung-Sheng Lin; Shin-Da Lee; Wei-Wen Kuo; Chih-Yang Huang
Journal:  Mol Cell Biochem       Date:  2006-04-21       Impact factor: 3.396

4.  Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer.

Authors:  T A Järvinen; M Pelto-Huikko; K Holli; J Isola
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

5.  Breast imaging: A survey.

Authors:  Subbhuraam Vinitha Sree; Eddie Yin-Kwee Ng; Rajendra U Acharya; Oliver Faust
Journal:  World J Clin Oncol       Date:  2011-04-10

Review 6.  The value of adjuvant treatment in young women with breast cancer.

Authors:  Sally Clive; J Michael Dixon
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  PTIP associated protein 1, PA1, is an independent prognostic factor for lymphnode negative breast cancer.

Authors:  Takashi Takeshita; Mutsuko Yamamoto-Ibusuki; Yutaka Yamamoto; Yoko Omoto; Yumi Honda; Ken-ichi Iyama; Zhenhuan Zhang; Hirotaka Iwase
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

8.  Wild-type oestrogen receptor beta (ERbeta1) mRNA and protein expression in Tamoxifen-treated post-menopausal breast cancers.

Authors:  P A O'Neill; M P A Davies; A M Shaaban; H Innes; A Torevell; D R Sibson; C S Foster
Journal:  Br J Cancer       Date:  2004-11-01       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.